최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.44 no.3, 2023년, pp.387 - 401
허나연 (우석대학교 한의과대학 내과학교실) , 안수빈 (우석대학교 한의과대학 내과학교실) , 김홍준 (우석대학교 한의과대학 방제학교실) , 장인수 (우석대학교 한의과대학 내과학교실)
Objective: This study was conducted to investigate the preventive effect of herbal medicines on restenosis after percutaneous coronary intervention (PCI) by reviewing randomized controlled trials (RCTs). Methods: RCTs were searched for herbal medicine treatment after PCI using eight online databases...
Sasaki S. Cardiovascular and neurological medicine?in Korean medicine II. Seoul: Woori medical?books; 2016, p. 134-47.
Statistics Korea. 2021 annual report on the?causes of deaths statistics [Internet]. Daejeon?(KR): Statistics Korea; 2021 [cited 2021 Sep?26]. Available from: https://www.index.go.kr/unity/potal/main/EachDtlPageDetail.do?idx_cd1012.
Roth GA, Mensah GA, Johnson CO, Addolorato?G, Ammirati E, Baddour LM, et al. Global?burden of cardiovascular diseases and risk?factors, 1990-2019: Update from the GBD 2019?Study. J Am Coll Cardiol 2020;76(25):2982-3021.
Ang YX, Khudzari AZM, Ali MSM. Non-invasive?treatment for coronary in-stent restenosis via?wireless revascularization with nitinol active Stent.?IEEE Trans Biomed Eng 2021;68(12):3681-9.
Lawton JS, Tamis-Holland JE, Bangalore S,?Bates ER, Beckie TM, Bischoff JM, et al. 2021?ACC/AHA/SCAI guideline for coronary artery?revascularization: a report of the american?college of cardiology/american heart association?joint committee on clinical practice guidelines.?Circulation 2022;145(3):e18-e114.
Lansky A, Grubman D, Scheller B. Paclitaxelcoated balloons: a safe alternative to drug-eluting?stents for coronary in-stent restenosis. Eur Heart?J 2020;41(38):3729-31.
Iakovou I, Schmidt T, Bonizzoni E, Ge L,?Sangiorgi GM, Stankovic G, et al. Incidence,?predictors, and outcome of thrombosis after?successful implantation of drug-eluting stents.?JAMA 2005;293(17):2126-30.
Rosand J, Eckman MH, Knudsen KA, Singer?DE, Greenberg SM. The effect of warfarin and?intensity of anticoagulation on outcome of?intracerebral hemorrhage. Arch Intern Med 2004;164(8):880-4.
Bae SE, Kim SE, Jung SA, Yoon SY, Shim KN,?Jung HK, et al. The effect of aspirin alone or?aspirin plus additional antiplatelets therapy on?upper gastrointestinal hemorrhage. Korean J?Gastroenterol 2011;57(4):213-20.
Song SH, Choi JA. A study on the trend of?world traditional medicine and key area of?traditional Korean medicine(TKM) R&D. Korea?J Orient Med 2010;16(1):101-9.
Min SW, Kim HK, Moon JS, Kim YS, Park?JY, Jeong JC. Case report of Korean medical?treatment of chest pain after percutaneous?coronary intervention. J Int Korean Med 2021;42(2):184-96.
Hui J, Yuan R, Li P, Xin Q, Miao Y, Shen?X, et al. Efficacy and safety of different courses?of Tongxinluo capsule as adjuvant therapy for?coronary heart disease after percutaneous coronary?intervention: a systematic review and meta-analysis of randomized controlled trials. J Clin?Med 2022;11(11):2991.
Xu G, Lin B, Mao Z, Zhang M. Meta-analysis?of the clinical efficacy and safety of Xiongshao?capsule in the treatment of in-stent restenosis?after PCI. Chin J Integr Med Cardio/Cerebrovas?Dis 2022;20(22):4045-51.
Chen Y, Xue C, Yang D, Yao R, Li L, Huang?L. Evaluating the advantages of traditional?Chinese medicine for supplementing qi and?promoting blood circulation method in the?prevention and treatment of ISR after PCI?based on meta-analysis. Chin J Integr Med?Cardio/Cerebrovas Dis 2022;20(14):2497-507.
Du Y, Song C, Jiaerken A, Wang X. Meta-analysis?on efficacy of yiqi huoxue Chinese drugs in the?treatment of coronary heart disease after coronary?revascularization. Medicinal Plant 2019;10(03):69-76.
Luo X, Huang B. Meta-analysis of clinical?effect of combined phlegm-eliminating and?blood-stasis-removing herbs on restenosis after?PCI. Guiding J Tradit Chin Med Pharmacol?2020;26(11):131-7.
Ren Y, Chen K, Ruan X, Wu H, Ou A, Wang?Y, et al. Systematic review of randomized?controlled trials on preventing and treating?restenosis after percutaneous coronary intervention?with Chinese medicine. Chin J Integr Med?2008;07:597-601.
Wu J, Zhao L, Lin K, Lu L, Luo C. Chinese?herbal medicines for restenosis after percutaneous?coronary intervention: a meta-analysis of?randomized controlled trials. J Altern Complement?Med 2019;25(10):983-92.
Liu S. Application effect of Tongxinluo capsule?combined with clopidogrel and aspirin in?patients with coronary heart disease after PCI.?Clin Res Pract 2019;4(19):127-31.
Zhou X, Li L, Yang K, Sun L. Clinical?observation of Gualou Xiebai granule in the?treatment of PCI postoperative restenosis in?soft plaque of coronary artery with syndrome?of phlegm-dampness blocking. Shanghai J Tradit?Chin Med 2017;51(11):41-4.
Hu X, Cao Z, Wang S, Wang J. Clinical observation?of Yan 's Wenyang Huoxue recipe in the?prevention and treatment of restenosis after?percutaneous coronary intervention. Shanghai J?Tradit Chin Med 2017;51(04):59-62.
Liu L, Jiang T. The influence of Tongxinluo?capsule and atorvastatin on in-stent restenosis?and inflammatory factors after percutaneous?coronary intervention. Chin J Integr Med Cardio/Cerebrovas Dis 2017;15(07):769-71.
Wang K, Yu Z. Clinical effect of Huxinkang?tablets in treatment of restenosis after percutaneous?coronary interventionin patients with coronary?heart disease. Hunan J Tradit Chin Med 2016;32(12):7-9.
Sun Q. Efficacy of integrated traditional Chinese?and western medicine in prevention of restenosis?after percutaneous coronary intervention. J New?Chin Medicine 2016;48(02):31-3.
Tang M, Peng X, Yan S. Effects of prostaglandin?E1 combined with Tongxinluo capsule on PCI?inflammatory factor and restenosis. J Hunan?Univ Chin Med 2015;35(06):54-6.
Niu X, Zhao Y, Zhang X, Li D, Xu Y, Cui C.?41 Cases of restenosis in patients with coronary?heart disease after PCI with Jingqi Danshen?Yin. J Tradit Chin Med 2012;53(17):1503-4.
Cheng S, Fang X, He J, Wang Q. Effect of?Anxin granule on the restenosis after percutaneous?coronary intervention. J Tradit Chin Med 2010;51(07):603-6.
Kim SY, Park JE, Seo HJ, Lee YJ, Jang HB,?Son HJ, et al. NECA's guidance for undertaking?systematic reviews and meta-analyses for?intervention. Seoul: National evidence-based?healthcare collaborating agency; 2011, p. 65-70,?172-5.
Kim WJ, Cho JH, Jung JH, Lee MK, Yoon?JS, Ahn YS, et al. Clinical comparison of?drug-eluting stents and bare metal stents in?large coronary arteries. Korean J Med 2011;80(6):664-71.
Kim MS, Dean LS. In-stent restenosis. Cardiovasc?Ther 2011;29(3):190-8.
Kim YS, Kim KK, Hwang IC. Aspirin usage based?on evidence for the prevention of cardio-cerebrovascular disease. Korean J Fam Med?2009;30(4):249-60.
Sasaki S. Cardiovascular and neurological medicine?in Korean medicine I. Seoul: Woori medical?books; 2016, p. 117-33.
Berman NG, Parker RA. Meta-analysis: neither?quick nor easy. BMC Med Res Methodol 2002;2(1):10.
Kim YJ, Park OJ. A survey on patients' compliance?with follow-up coronary angiogram after coronary?intervention. Korean J Adult Nurs 2000;12(1):30-9.
Wang Z, Gong C, Li Z. Research progress of the?molecular mechanism of Tongxinluo capsule?treatment in cardio-cerebrovascular diseases.?Chin J Emerg Med 2010;19(12):2112-4.
Fan X. Thirty-one cases of modified Gualou?Xiebai Banxia decoction for treatment of the?coronary heart disease with chronic heart failure?with phlegm-turbid obstruction, qi stagnation?and blood stasis type. Henan Tradit Chin?Med 2012;32(09):1122-3.
He Q, Wang J. Research on TCM syndromes?and diagnosis of patients after percutaneous?coronary intervention based on cluster analysis.?J Tradit Chin Med 2008;10:918-21.
Lee CH. Standards of medical care in percutaneous?coronary intervention. Korean J Med 2012;83(2):233-5.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.